The subjectivity and inaccuracy of in-clinic Cognitive Health Assessments (CHA) have led
many researchers to explore ways to automate the process to make it more objective and to …

In the last decade, extensive research has emerged into understanding the impact of risk
factors for Alzheimer's Disease (AD) on brain in pre-symptomatic stages. We investigated …

Brain functional connectivity in dementia has been assessed with dissimilar EEG
connectivity metrics and estimation procedures, thereby increasing results' heterogeneity. In …

Background Analysis of functional brain networks in Alzheimer's disease (AD) has been
hampered by a lack of reproducible, yet valid metrics of functional connectivity (FC). This …

Resting-state neural oscillations are used as biomarkers for functional diseases such as
dementia, epilepsy, and stroke. However, accurate interpretation of clinical outcomes …

Introduction Harmonization protocols that address batch effects and cross‐site
methodological differences in multi‐center studies are critical for strengthening …

Understanding the role of Tau protein aggregation in the pathogenesis of Alzheimer's
disease is critical for the development of new Tau-based therapeutic strategies to slow or …

The present study aimed to explore the potential neural correlates during feedback
evaluation during decision-making under risk and ambiguity in MCI. Nineteen individuals …

With increasing life span and prevalence of dementia, it is important to understand the
mechanisms of cognitive aging. Here, we focus on a subgroup of the population we term …

Alzheimer's disease (AD) is characterized by the accumulation of amyloid-β and misfolded
tau proteins causing synaptic dysfunction, and progressive neurodegeneration and …